Importantly, Figure 7M and Supplemental Figure 7L show that the LAL levels were decreased not only in the whole blood cells but also in CD11c+, PD-L1+, and CSF1R+ cells of patients with NSCLC compared with healthy controls. This evidence concerns the gene CSF1R and non-small cell lung carcinoma.